Lil Mixins
Primary prevention of food allergies in infants
CommercialActive
Key Facts
Indication
Primary prevention of food allergies in infants
Phase
Commercial
Status
Active
Company
About Hanimune Therapeutics
Hanimune Therapeutics is a private biotechnology company developing consumer and therapeutic food products for the prevention and management of food allergies. Its core strategy involves the early introduction of precise, reliable quantities of allergenic proteins to build immune tolerance. The company's portfolio includes 'Lil Mixins' for infant diets and 'Top9Proteins' for supporting tolerance at any age, positioning it at the intersection of nutritional science, consumer health, and immunology. Hanimune operates in a high-growth market with significant unmet need, aiming to transform allergy care from reactive avoidance to proactive tolerance building.
View full company profile